BCH 4054 HOUR TEST 3 NAME _____________________ November 13, 1995 (12) 1. Draw the structures of guanine and cytosine, and circle the nitrogen atoms in each that are derived biosynthetically from glutamine. (8) 2. Inosine monophosphate is the common precursor of AMP and GMP. Identify by giving all of the reactants and products of (structures not necessary): (a) The GTP requiring reaction between IMP and AMP. (b) The ATP requiring reaction between IMP and GMP. (10) 3. The enzyme AMP deaminase converts AMP to IMP and NH4+. If this reaction is coupled to the two steps in which synthesis of AMP from IMP occurs (i.e., IMP ----> intermediate -----> AMP), the sum of the three reactions forms a cycle. Write out these three reaction steps, showing other reactants and products (structures not necessary), and then give the overall reaction catalyzed by the cycle. (This is called the purine nucleotide cycle, and is believed to play an important metabolic role in muscle.) (6) 4. The regulation of nucleotide biosynthesis is complex, with various nucleotides serving as regulatory effectors. Match the nucleotides in the list at the right with the enzymes and the effects indicated in the list at the left by putting the appropriate number or numbers in the blank. (More than one nucleotide may apply). ____ Inhibition of aspartate transcarbamoylase (1) ATP (2) dATP ____ Activation of aspartate transcarbamoylase (3) GMP (4) CTP ____ Inhibition of ribonucleotide reductase (5) AMP (6) UMP ____ Inhibition of IMP ---> XMP ____ Inhibition of carbamoyl phosphate synthetase II ____ Inhibition of PRPP ---> phosphoribosylamine (5) 5. Ribonucleotide reductase has two kinds of allosteric sites. Explain what property of the enzyme each site regulates. What is the rationale for such a complex regulatory mechanism? (5) 6. The purine and pyrimidine biosynthetic pathways are complicated by the fact that some processes occur at the monophosphate level, some at the diphosphate level, and some at the triphosphate level. For each of the following, indicated in the blank whether a nucleoside mono-, di-, or tri- phosphate is involved. _______ Amination of the uracil ring to form cytosine. _______ Decarboxylation of orotic acid. _______ Methylation of the uracil ring to form thymine. _______ Amination of the hypoxanthine ring to form guanine. _______ Reduction of ribose to deoxyribose. (7) 7. You have prepared DNA from two organisms isolated from the swamps of south Georgia, designated culture A and culture B. DNA from culture A contains 24% G, while DNA from culture B contains 30% G. Complete the following table for the expected composition of the other purine and pyrimidine bases. %G %A %T %C Total Culture A 24 ____ ____ ____ 100% Culture B 30 ____ ____ ____ 100% DNA from which organism will have the higher melting temperature? (6) 8. Denaturing DNA by increasing the temperature is sometimes called "melting". What changes occur upon melting in: (a) the secondary structure of DNA? (b) absorbance at 260 nm? (c) viscosity of the DNA solution? (8) 9. From the following DNA sequences, write the complementary sequence under it (in the 3' to 5' direction), and circle the bases of the resulting double stranded DNA which are palindromic sequences at least four base pairs in length. (a) 5'-GCTTCGAAC-3' (b) 5'-CTACTACTA-3' 3'- 3'- (c) 5'-GCGCAACG-3' (d) 5'-TTATTGCAAG-3' 3'- 3'- (6) 10. Suppose that negatively supercoiled DNA with L=23, T=25, and W=-2 is acted upon by topoisomerase I. After one catalytic cycle, what would be the values of L, T, and W? Suppose that negatively supercoiled DNA with L=23, T=25, and W=-2 is acted upon by DNA gyrase and ATP. After one catalytic cycle, what would be the values of L, T, and W? (6) 11. Describe an Okasaki fragment. When and where is it made, and what happens to it? (9) 12. Explain the roles of helicases, DNA topoisomerase II, and SSB protein in DNA replication. (6) 13. What is the function of the 3'-5' exonuclease activity of bacterial DNA polymerase III? (6) 14. What is the function of the 5'-3' exonuclease activity of bacterial DNA polymerase I.